Supernus Pharmaceuticals, Inc.
SUPN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356576
No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.
13F holders, Q1 2021
Institutional positions in Supernus Pharmaceuticals, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 224
- No complete 13F data for Q4 2020
- Shares held
- 53.4M
- No complete 13F data for Q4 2020
- Total value
- $1.40B
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting SUPN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 334 | $2.80B |
| Q1 2026 | 328 | $3.01B |
| Q4 2025 | 333 | $2.84B |
| Q3 2025 | 310 | $2.76B |
| Q2 2025 | 295 | $1.87B |
| Q1 2025 | 295 | $1.94B |
| Q4 2024 | 294 | $2.15B |
| Q3 2024 | 273 | $1.87B |
| Q2 2024 | 245 | $1.56B |
| Q1 2024 | 251 | $1.93B |
| Q4 2023 | 245 | $1.65B |
| Q3 2023 | 239 | $1.57B |
| Q2 2023 | 249 | $1.72B |
| Q1 2023 | 259 | $2.01B |
| Q4 2022 | 264 | $1.99B |
| Q3 2022 | 244 | $1.88B |
| Q2 2022 | 225 | $1.58B |
| Q1 2022 | 230 | $1.75B |
| Q4 2021 | 235 | $1.61B |
| Q3 2021 | 224 | $1.45B |
| Q2 2021 | 226 | $1.67B |
| Q1 2021 | 224 | $1.40B |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding Supernus Pharmaceuticals, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HealthInvest Partners AB | 534,000 | $14.0M | 11.13% | – | – |
| Bank of America Corp | 560,263 | $14.7M | 0.00% | – | – |
| Glenmede Trust Co NA | 569,461 | $14.9M | 0.08% | – | – |
| Northern Trust Corp | 589,857 | $15.4M | 0.00% | – | – |
| Price T Rowe Associates Inc | 608,383 | $15.9M | 0.00% | – | – |
| Bank of New York Mellon Corp | 656,678 | $17.2M | 0.00% | – | – |
| Invesco Ltd. | 727,283 | $19.0M | 0.01% | – | – |
| Ameriprise Financial Inc | 764,977 | $20.0M | 0.01% | – | – |
| Frontier Capital Management Co LLC | 769,523 | $20.1M | 0.15% | – | – |
| FMR LLC | 805,574 | $21.1M | 0.00% | – | – |
| Geode Capital Management, LLC | 869,624 | $22.8M | 0.00% | – | – |
| Aristotle Capital Boston, LLC | 973,293 | $25.5M | 0.57% | – | – |
| LSV Asset Management | 1,024,300 | $26.8M | 0.05% | – | – |
| Rice Hall James & Associates, LLC | 1,035,089 | $27.1M | 0.88% | – | – |
| Stephens Investment Management Group LLC | 1,140,519 | $29.9M | 0.43% | – | – |
| Ashford Capital Management Inc | 1,231,228 | $32.2M | 3.01% | – | – |
| GW&K Investment Management, LLC | 1,573,411 | $41.2M | 0.38% | – | – |
| Renaissance Technologies LLC | 1,760,222 | $46.1M | 0.06% | – | – |
| State Street Corp | 1,777,662 | $46.5M | 0.00% | – | – |
| Macquarie Group Ltd | 2,083,718 | $54.6M | 0.08% | – | – |
| Dimensional Fund Advisors LP | 2,132,092 | $55.8M | 0.02% | – | – |
| Armistice Capital, LLC | 3,412,000 | $89.3M | 2.86% | – | – |
| Vanguard Group Inc | 5,454,555 | $142.8M | 0.00% | – | – |
| BlackRock Inc. | 8,994,226 | $235.5M | 0.01% | – | – |